Mumbai City Football Club have renewed their partnership with healthcare institution Nanavati Max Super Specialty Hospital, which will thus continue on as the club’s Official Medical Partner for the 2023/24 season.
As per the agreement, apart from gaining branding rights across club assets, Nanavati Max Super Specialty Hospital will provide medical care and support to the Mumbai City players and even the spectators at the team’s home games at the Mumbai Football Arena.
Kandarp Chandra, CEO – Mumbai City FC, stated:
“We are delighted to continue our partnership with one of Mumbai’s finest medical institutions in Nanavati Max Super Speciality Hospital. The medical care and assistance provided to our players, staff and, as well as to the fans at the Mumbai Football Arena is unmatched, and we’re looking forward to our renewed relationship.“
Mangla Dembi, Senior Vice President and Head – Nanavati Max Super Speciality Hospital, Mumbai, added:
“Nanavati Max Super Specialty Hospital is immensely proud to be the official medical partner of Mumbai City FC in the upcoming season of the Indian Super League. Together, we share a commitment to excellence, passion, and the well-being of every player. As the Islanders strive for glory on the pitch, we, as the leading care healthcare provider of the city, pledge our unwavering support, ensuring the best medical care for our champions. We wish our city’s home team a season of great health, incredible sportsmanship, and memorable victories.“
South Africa and South Korea face each other knowing that both have a good chance…
A settled and confident Morocco side will take on Haiti knowing that they already have…
Bosnia and Herzegovina enter into this fixture against Qatar with a once-in-a-lifetime opportunity of qualifying…
Scotland and Brazil will face each other on 25th June at the Miami Stadium in…
As the grass court season gets underway, tennis fans around the world eagerly anticipate the…
Formula One has signed a new long-term partnership with global live-entertainment technology platform, Fever, who…